by Rxisk:
" we have also been putting together a petition to the Food and Drug Administration (FDA), requesting changes to SSRI and SNRI product labels to warn about post-SSRI sexual dysfunction (PSSD) and persistent genital arousal disorder (PGAD). The petition sets out in detail the nature of the problem, the history of the conditions, and what needs to be done about it.
As an extra measure we also sent it to the journal, and they accepted it for publication. This means the petition itself becomes a publication in a peer-reviewed journal and adds to the literature on PSSD and PGAD. The journal also very generously agreed to make it open access at no additional cost.
Citizen petition: Sexual side effects of SSRIs and SNRIs is available for download: https://rxisk.org/wp-content/uploads/2018/05/JRS745.pdf
We consulted the FDA website for details on what to include, so if the wording looks stilted at some points, this stems from FDA requirements rather than our design.
In addition to FDA, we have also submitted the petition to the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), to request changes to European and UK drug labels.
We will be sending details of the new paper and petition to as many groups as possible, but we also need your help to promote them via social media, online forums, or any other networks that you have. You might want to print out copies and give them to your doctor. Another idea might be to print out several copies and mail them to every GP at your local medical practice – or maybe every urologist at your local hospital. If you have links to the media or other groups that might take an interest in these issues, please send them a copy.
We would like to thank the PFS Foundation for giving us the idea for the petition in the first place. "